← Leaderboards
Laura Bracaglia
Univ Of Maryland, College Park
$1,039,923
Attributed
$1,039,923
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $354.7K · FY2016–24$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,039,923 · 3
By mechanism
R00$800,484 · 1
K99$211,432 · 1
F31$28,007 · 1
Top collaborators
No co-investigators on record.
Most similar at Univ Of Maryland, College Park
Same institution · by research overlap
- Peter Kofinas$2,294,527
- Jesse Kenneth Placone$115,284
- John Louis Daristotle$42,182
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseInjuryInjuredPreventDesignCellsImmuneInflammationIn VitroPolymersSiteTissuesNatural RegenerationIn VivoEndothelial CellsExtracellular MatrixBlood VesselsInfiltrationBiomedical EngineeringBiologyDoctor Of PhilosophyDensityCell Adhesion MoleculesArea
Grant awards (7)
Tailored siRNA delivery to human endothelium to inhibit and reverse inflammatory damage following ischemia reperfusion injury in the kidney$245,275
R00 · FY2024 · HL · contact PI
Tailored siRNA delivery to human endothelium to inhibit and reverse inflammatory damage following ischemia reperfusion injury in the kidney$58,434
R00 · FY2024 · HL · contact PI
Tailored siRNA delivery to human endothelium to inhibit and reverse inflammatory damage following ischemia reperfusion injury in the kidney$247,775
R00 · FY2023 · HL · contact PI
Tailored siRNA delivery to human endothelium to inhibit and reverse inflammatory damage following ischemia reperfusion injury in the kidney$249,000
R00 · FY2022 · HL · contact PI
Tailored siRNA delivery to human endothelium to inhibit and reverse inflammatory damage following ischemia reperfusion injury in the kidney$105,716
K99 · FY2022 · HL · contact PI
Tailored siRNA delivery to human endothelium to inhibit and reverse inflammatory damage following ischemia reperfusion injury in the kidney$105,716
K99 · FY2021 · HL · contact PI
Development of a Hybrid Material for a Tissue Engineered Strategy to Reconstruct the Vascular Wall$28,007
F31 · FY2016 · HL · contact PI